Efficacy and safety of radiofrequency ablation and transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: A meta-analysis.
OBJECTIVE
To investigate the efficacy and safety of radiofrequency ablation (RFA) and transcatheter arterial chemoembolization (TACE) for treatment of patients with hepatocellular carcinoma (HCC).


METHODS
All eligible studies were collected from PubMed, the Cochrane Libraries and Embase. The evaluation indices included overall survival (OS) rate, recurrence-free survival rate, local tumor progression rate and major complications. All statistical analysis was performed by RevMan version 5.2 software.


RESULTS
There were 21 studies with 3073 patients included in this meta-analysis. The RFA monotherapy was associated with higher 3- and 5-year OS rates (OR3-year  = 2.33, 95% confidence interval [CI] = 1.34-4.05; OR5-year  = 2.05, 95% CI = 1.48-2.85) compared with TACE alone. The combination of RFA and TACE was associated with higher 1-, 3- and 5-year OS rates (OR1-year  = 1.94, 95% CI = 1.28-2.96; OR3-year  = 1.56, 95% CI = 1.19-2.04; OR5-year  = 1.53, 95% CI = 1.13-2.07) compared with RFA alone.


CONCLUSIONS
The combination of TACE with RFA could obviously improve the short- and long-term survival rates and significantly provide a better prognosis for patients with intermediate-size HCC. RFA was associated with a higher long-term OS rate than that of TACE-treated patients with HCC.
Department of Gastroenterology, Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yulan
Y
Wang
Department of Urology, Second Affiliated Hospital, Third Military Medical University, Chongqing, China.
Tianxing
T
Deng
Department of Gastroenterology, Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Li
L
Zeng
Department of Gastroenterology, Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Weiqing
W
Chen
hepatocellular carcinoma; meta-analysis; radiofrequency ablation; transcatheter arterial chemoembolization